4.7 Article

Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy

期刊

ACTA PHARMACEUTICA SINICA B
卷 11, 期 12, 页码 3966-3982

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.06.007

关键词

PINK1-Parkin-mediated mitophagy; Magnolol; Combination therapy; Apoptosis; Tumor suppression

资金

  1. Innovation and Technology Fund (China) of Hong Kong [PRP/036/20FX]
  2. Health and Medical Research Fund (China) of Hong Kong [MHRF-16170251]
  3. Singapore Ministry of Education (MOE) Tier 2 (Singapore) [MOE2018-T2-1-060]
  4. National Natural Science Foundation of China [82074123, 31501116, 82071441]

向作者/读者索取更多资源

This study demonstrates that the natural product magnolol can induce mitochondrial depolarization, excessive fragmentation, and increased reactive oxygen species production. Magnolol also induces mitophagy through positive feedforward loops and triggers cancer cell death via the intrinsic apoptosis pathway, leading to inhibition of tumor growth and prolonged survival in mice. Inhibition of mitophagy enhances the anticancer efficacy of magnolol, suggesting that targeting mitophagy may be a promising strategy for improving cancer therapy.
Mitochondria as a signaling platform play crucial roles in deciding cell fate. Many classic anticancer agents are known to trigger cell death through induction of mitochondrial damage. Mitophagy, one selective autophagy, is the key mitochondrial quality control that effectively removes damaged mitochondria. However, the precise roles of mitophagy in tumorigenesis and anticancer agent treatment remain largely unclear. Here, we examined the functional implication of mitophagy in the anticancer properties of magnolol, a natural product isolated from herbal Magnolia officinalis. First, we found that magnolol induces mitochondrial depolarization, causes excessive mitochondrial fragmentation, and increases mitochondrial reactive oxygen species (mtROS). Second, magnolol induces PTEN-induced putative kinase protein 1 (PINK1)-Parkin-mediated mitophagy through regulating two positive feedforward amplification loops. Third, magnolol triggers cancer cell death and inhibits neuroblastoma tumor growth via the intrinsic apoptosis pathway. Moreover, magnolol prolongs the survival time of tumor-bearing mice. Finally, inhibition of mitophagy by PINK1/Parkin knockdown or using inhibitors targeting different autophagy/mitophagy stages significantly promotes magnolol-induced cell death and enhances magnolol's anticancer efficacy, both in vitro and in vivo. Altogether, our study demonstrates that magnolol can induce autophagy/mitophagy and apoptosis, whereas blockage of autophagy/mitophagy remarkably enhances the anticancer efficacy of magnolol, suggesting that targeting mitophagy may be a promising strategy to overcome chemoresistance and improve anticancer therapy. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据